Ophthalmology and Optometry articles for Fudan University, China

Time frame: 1 June 2025 - 30 May 2026

View topic

Count: 14

Article ‘Count’ for Ophthalmology and Optometry.

Journal Count Share
2 1.30
Self-Adaptive Hydrogen Nano-Delivery System in Glaucoma Management: Synergistic Antioxidation and Anti-inflammation Therapeutic Strategy 0.55
Human Corneal Lenticules Decorated with Mesenchymal-Stem-Cells-Encapsulated Microneedles for Cornea Stroma Regeneration 0.75
1 0.52
Lightweight, elastic and bioactive scaffolds with enhanced vascularization and anti-inflammation for post-enucleation orbital reconstruction 0.52
2 1.15
Framework Nucleic Acids Nanoplatform Regulating Cellular Stemness and Oxidative Microenvironment for Synergistic Treatment of Ocular Surface Disorders 0.72
Electrostatically Engineered Polyoxometalate Contact Lenses for Integrated Shielding of UV Radiation and Ozone‐Induced Ocular Stress 0.43
1 0.68
Disrupting the Oxidative Stress–Inflammation–Corneal Neovascularization Cycle with Ultrasmall Nanoparticles 0.68
2 0.88
Nanostructured High-Entropy Yolk–Shell Oxides Platform for Efficient Metabolic Profiling of Diabetic Retinopathy 0.50
Multicenter Validation of Metabolomic Fingerprints for Accurate Diagnosis, Subtyping, and Severity Stratification of Glaucoma 0.38
2 0.67
Routine blood tests and machine learning identify complications in high myopia 0.67
Chemical reprogramming of fibroblasts into retinal pigment epithelium cells for vision restoration 0.00
1 0.09
S.T.O.P kit for Myopia Control: Stage 1 results from a randomized controlled clinical trial in Chinese children. 0.09
1 0.08
Feedback regulation between histone lactylation and ALKBH3-mediated glycolysis regulates age-related macular degeneration pathology 0.08
2 0.76
Functional targeting of PTTG1 in pericytes restores vascular integrity in diabetic retina 0.12
Thermoresponsive antioxidant metal-free carbon nanodot hydrogel: An effective therapeutic approach for ocular surface disease 0.64

Numerical information only (in the tables above) is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International.